The Navigator Project (NAV)

June 15, 2015 updated by: University of California, San Francisco

Navigator-Enhanced Case Management for HIV-Infected Jail Inmates Reentering the Community

Each year, there are over 600 unduplicated HIV-infected persons incarcerated in the San Francisco jail. Two thirds of those released with HIV-focused discharge planning are reincarcerated within one year. More than half of HIV-infected jail inmates are diagnosed with mental health conditions severe enough to require medication and a similar proportion report substance use disorders at the time of detention. While some community-based services exist, there remains a critical need to improve linkages to care and adherence to care plans for HIV-infected adults as they move between community and jail. The Navigator Project is a five-year randomized study that will test the effectiveness of an intensive enhanced case management intervention to reduce sex and drug-related HIV transmission risk; increase HIV medication adherence; reduce drug dependence; and reduce reincarceration.

Study Overview

Study Type

Interventional

Enrollment (Actual)

271

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • California
      • San Francisco, California, United States, 94102
        • Tenderloin Clinical Research Foundation

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Detention in the San Francisco jail system
  • Confirmed HIV infection
  • Lifetime history of ever having met standardized criteria for drug or alcohol addiction
  • Likely release back into San Francisco without transfer to another facility
  • Agreement to work with Forensic AIDS Project to plan post-release care
  • Able and willing to provide informed consent
  • Not scheduled for release within 36 hours

Exclusion Criteria:

  • Undocumented HIV status
  • Inability to speak English or Spanish
  • Unable or unwilling to provide informed consent
  • Not under routine level of jail security

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: FAP counseling
Control arm utilizing the standard of care: access to services provided by the Forensic AIDS Project for up to 90 days after release
The Forensics AIDS Project provides primary care to HIV-infected detainees, as well as up to 90 post-release case-management services which include discharge planning.
Experimental: Navigator enhanced case-management
Experimental arm: access to Navigator enhanced case-management services for one year after release
Patient navigators are non-clinical, paraprofessional peers who are HIV-infected and have lifetime histories of detention and substance abuse. Working with the patient, they facilitate adherence to a comprehensive care plan designed to address clients' multiple risks and needs. Patients have access to Navigator services for one year after study enrollment.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
substance use
Time Frame: 2 months, 6 months, 12 months
change from baseline in self-reported drug and alcohol use, measured by a survey tool, and actual use of five drugs (methamphetamine, cocaine, tetrahydrocannabinol, opiates, and benzodiazepines), measured by a urine screen, at three time points each
2 months, 6 months, 12 months
recidivism
Time Frame: 12 months
number of times re-detained during the twelve-month study period, collected from jail records
12 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
sexual risk behavior
Time Frame: 2 months, 6 months, 12 months
change from baseline in self-reported sexual risk behaviors, measured by a survey tool at three time points after the initial detention
2 months, 6 months, 12 months
adherence to HIV medications
Time Frame: 2 months, 6 months, 12 months
change from baseline in self-reported adherence (as a %) to antiretroviral therapy, measured by a survey tool at three time points after the initial detention
2 months, 6 months, 12 months

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
housing
Time Frame: 2 months, 6 months, 12 months
change from baseline in self-reported housing status, measured by a survey tool at three time points after the initial detention
2 months, 6 months, 12 months
medical coverage
Time Frame: 2 months, 6 months,12 months
change from baseline in self-reported insurance coverage, measured by a survey tool at three time points after the initial detention, and use of community health services and jail health services, measured continuously via a community database for 12 months after the initial detention
2 months, 6 months,12 months
needle use
Time Frame: 2 months, 6 months, 12 months
change from baseline in self-reported needle-use and needle-sharing, measured by a survey tool at three time points after the initial detention
2 months, 6 months, 12 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Janet J Myers, PhD, MPH, University of California, San Francisco

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

February 1, 2010

Primary Completion (Actual)

June 1, 2014

Study Completion (Actual)

June 1, 2014

Study Registration Dates

First Submitted

April 1, 2014

First Submitted That Met QC Criteria

April 3, 2014

First Posted (Estimate)

April 8, 2014

Study Record Updates

Last Update Posted (Estimate)

June 16, 2015

Last Update Submitted That Met QC Criteria

June 15, 2015

Last Verified

June 1, 2015

More Information

Terms related to this study

Other Study ID Numbers

  • R01DA027209 (U.S. NIH Grant/Contract)

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on HIV

Clinical Trials on Forensic AIDS Project

3
Subscribe